Illumina has become a powerhouse of the Chinese genomics …
Nov 21, 2022 · Illumina has been proactively fostering the industry’s growth in China by accelerating the introduction and launch of new products and technologies, like the NovaSeq X series— Illumina’s highest-throughput, highest-capacity, and most sustainable sequencing platform—which made its Asian debut at the fifth annual China International ...
Office Locations | Contact information - Illumina
Illumina Trading (Shanghai) Co., Ltd. 12F, Building #23, 1999 Yishan Road Shanghai Business Park Phase III, Shanghai 200233, China +86.21.6032.1066 (tel) +86.21.6090.6279 (fax) www.illumina.com.cn
Illumina Deepens Commitment to Customers in China with New ...
Aug 30, 2022 · The new Shanghai-based facility enables localized production for Illumina's gene sequencing instruments and consumables and reflects the growing demand in the Chinese market for Illumina's systems and products.
Illumina Scales for Growth in China
Mar 31, 2015 · Illumina’s HiSeq X Ten, which enabled the $1,000 genome, has been strongly adopted inside China. Some of the earliest adopters of this technology include Novogene and WuXi PharmaTech . Most recently, Cloud Health has invested in this platform.
Berry Oncology accelerates early liver cancer detection in China
Aug 22, 2021 · Jun Zhou is determined to make an impact on early cancer detection in China. The CEO of Berry Oncology, a subsidiary of Berry Genomics, is overseeing China’s first and only large-scale, forward-looking cohort study of early liver cancer screening based on next-generation sequencing (NGS) technology. It is also one of the largest and fastest ...
A golden age for China’s NGS industry - Illumina
May 19, 2021 · In working to build and empower this ecosystem, Illumina and Sequoia Capital China, a leading investment firm,, announced earlier this year a collaboration to catalyze Chinese startups with the launch of the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina.
NextSeq 550Dx approved for clinical use in China - Illumina
Dec 1, 2020 · With this approval, Illumina welcomes a wide range of IVD partners in China to develop testing products for clinical applications on the NextSeq 550Dx. In 2019 Illumina announced an agreement with European-based QIAGEN to develop and globally commercialize IVD kits to be used on the NextSeq 550Dx.
Illumina, Inc. - Illumina and Sequoia Capital China Partner to …
Jan 31, 2021 · Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina will leverage the expertise of Illumina for Startups in building genomics companies with the unparalleled track record of Illumina Accelerator in San …
China’s Novogene is a global force - Illumina
Jun 14, 2021 · In 2014, Novogene became one of the world’s first users of the Illumina HiSeq X Ten, a high-throughput sequencer. At that time, the system had the highest sequencing throughput, the greatest efficiency, and the lowest cost in China.
Illumina and Sequoia Capital China Select First Startups to join ...
SAN DIEGO, Nov. 17, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), and Sequoia Capital China, a leading investment firm, today jointly announced the selection of the first two startup companies joining the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered …